Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients
PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
November 30, 2012
Primary Completion Date
November 30, 2013
Study Completion Date
December 31, 2014
Conditions
it is a Group of Metabolic Diseases inWhich a Person Has High Blood Sugar, EitherBecause the Body Does Not Produce Enough Insulin,or Because Cells do Not Respond to the Insulin Thatis Produced.
Interventions
DRUG
Taurine
500 mg taurine capsules twice per day for 6 months